Moderna COVID-19 vaccine appears to work as well in older adults in early study


  • World
  • Wednesday, 26 Aug 2020

FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder/File Photo

(Reuters) - Moderna Inc said on Wednesday its experimental COVID-19 vaccine induced immune responses in older adults similar to those in younger participants, offering hope that it will be effective in people considered to be at high risk for severe complications from the coronavirus.

The company is one of the leading contenders in the race to develop a vaccine against the virus that has killed more than 820,000 people worldwide. Its candidate, mRNA-1273, is already in late-stage human trials testing its ability to safely prevent infection.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Protesters say Fico dragging Slovakia to Russia in Ukraine gas dispute
Canada imposes sanctions on 14 Venezuelan officials
Greenland's leader ready to talk to Trump
Tanzania forecast to register 1,500 investment projects worth 15 bln USD in 2025: minister
Foreign tourist arrivals to Sarajevo hit record high since COVID-19
Two policemen killed in Belarus
Oil pollution spreads across parts of Crimean coastline
IMF acknowledges resilience of Hong Kong's financial system
China's 2024 data market transaction volume tops 160 billion yuan
Canada foreign minister won't run to replace Trudeau, cites US tariff threat

Others Also Read